Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Apie Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Apie Therapeutics

Apie Therapeutics

APIE Therapeutics: Global developer of anti-fibrosis therapies for improved health outcomes.

HQ
Cary, NC, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to improve health outcomes globally, Apie Therapeutics focuses on developing anti-fibrosis therapies. The company aims to create a portfolio of therapeutic drugs that enhance the body's natural repair and regeneration processes. Their core vision is to leverage scientific expertise and dedication to address debilitating and often fatal diseases caused by the breakdown of optimal repair and healthy wound-healing mechanisms.

Notable figures affiliated with Apie Therapeutics include leading scientists and healthcare professionals dedicated to pioneering novel therapeutics. The company has garnered attention from key investors in the biotech sector, underscoring its potential impact. Apie Therapeutics' significant achievements include advancing their drug portfolio and contributing to the broader understanding of fibrosis-related conditions, ultimately aiming to transform patient care and treatment outcomes.

Apie Therapeutics - Similar Companies

Apic Bio logo

Apic Bio

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Blade Therapeutics logo

Blade Therapeutics

Apexian Pharmaceuticals logo

Apexian Pharmaceuticals

apexianpharma.com

Appia Bio logo

Appia Bio

appiabio.com

Applied Therapeutics logo

Applied Therapeutics

Mediar Therapeutics logo

Mediar Therapeutics

mediartx.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Mistral Therapeutics logo

Mistral Therapeutics

SphynKx Therapeutics logo

SphynKx Therapeutics

Antios Therapeutics logo

Antios Therapeutics

Angion logo

Angion

elicio.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Aristea Therapeutics logo

Aristea Therapeutics

Pipeline Therapeutics logo

Pipeline Therapeutics

Apie Therapeutics - Quick Facts

Who are Apie Therapeutics' competitors?

Companies similar to Apie Therapeutics include Apic Bio, Pliant Therapeutics, Blade Therapeutics and Apexian Pharmaceuticals.

When was Apie Therapeutics founded?

Apie Therapeutics was founded in 2020.

Where is Apie Therapeutics' headquarters located?

Apie Therapeutics' headquarters is located in Cary, NC, US.

When was Apie Therapeutics' last funding round?

Apie Therapeutics' most recent funding round was for $25k (USD) in February 2021.

How much has Apie Therapeutics raised to-date?

As of Feb 3, 2021, Apie Therapeutics has raised a total of $25k (USD).

How many employees does Apie Therapeutics have?

Apie Therapeutics has 32 employees as of Feb 5, 2024.

Apie Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Anti-Fibrosis Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified